𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carboplatin in malignant mesothelioma: A phase II study of the cancer and leukemia Group B

✍ Scribed by Nicholas J. Vogelzang; Maria Goutsou; Joseph M. Corson; Yasunosuke Suzuki; Stephen Graziano; Joseph Aisner; M. Robert Cooper; Kristine Mason Coughlin; Mark R. Green

Publisher
Springer
Year
1990
Tongue
English
Weight
408 KB
Volume
27
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Vindesine: A phase II study in childhood
Vindesine: A phase II study in childhood malignancies-A report for cancer and leukemia group B
✍ Ettinger, Lawrence J. ;Brecher, Martin ;Coleman, Morton ;Smithson, W. Anthony ;P πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 538 KB

## Abstract Vindesine, a semisynthetic derivative of vinblastine sulfate, was tested for anti‐tumor activity and clinical toxicity in 36 children. The drug was administered to the initial 13 patients entered into the study a 2 mg/m^2^/day for five days by IV bolus. Because of severe neurotoxicity a

Phase II trial of cis-dichlorodiamminepl
Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: A study of the cancer and acute leukemia group B
✍ F. Cavalli; Dr. W. F. Jungi; N. I. Nissen; T. F. Pajak; M. Coleman; J. F. Hollan πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 279 KB πŸ‘ 3 views

In a cooperative study of the Cancer and Acute Leukemia Group B, 27 evaluable patients with advanced malignant lymphomas were treated with 70 mg/m2 of cisdichlorodiammineplatinum(l1) (cis-platinum) once every three weeks. All patients had received extensive prior therapy. Partial remission was obtai

Gemcitabine combined with carboplatin in
Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma : A multicentric Phase II study
✍ Adolfo G. Favaretto; Savina M. L. Aversa; Adriano Paccagnella; Vincenzo De Pangh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Malignant pleural mesothelioma (MPM) is increasing rapidly worldwide. Currently, pemetrexed plus cisplatin chemotherapy showed a survival advantage versus cisplatin alone. No impact on patient survival of surgery, radiotherapy, or their combination has been demonstrated.